-Ncardia, a leader in stem cell–based solutions for drug discovery and safety assessment, announced the launch of Ncyte® NHP-C vCardiomyo...
Illumina Inc. (NASDAQ: ILMN) will partner with multiple global pharmaceutical companies to develop companion diagnostics (CDx) enabled on the T...
Esperion announced that Otsuka Pharmaceutical Co., Ltd. (Otsuka), the Company’s partner for the development and commercialization of NEXLETOL® ...
Alvotech a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced th...
Polyrizon Ltd., a biotechnology company focusing on the development of intranasal products announced the submission of its full pre-submission (Pre-Sub) ...
Merck, a leading science and technology company, announced the official opening of its new Life Science manufacturing facility in Blarney, Ireland....
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, announced the opening of its new appl...
AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, annou...
Novartis receives an exclusive license to an undisclosed discovery target Novartis also receives options to license two programs from Monte Rosa’s...
Targeted proteomics panel delivers absolute quantification of key and emerging biomarkers in one scalable assay Thermo Fisher Scientific Inc., the world...
Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of its new IR820 and I...
Thermo Fisher Scientific Inc., the world leader in serving science, proudly announced its role as a founding sponsor of the newly launched LifeSciKY Co...
Full portfolio of QIAstat-Dx panels now CE-IVDR certified for use in clinical syndromic testing, underscoring commitment to highest-quality diagnosti...
Collaboration will help reduce stable cell line development timelines in AAV genomic medicine development and ultimately also shorten development timeline ...
© 2025 Biopharma Boardroom. All Rights Reserved.
